Carasent ASA incentive program for chairman and CEO to be replaced by investments in Carasent SWE shares

27 Sep 2024 16:35 CEST

Reference is made to Carasent ASA's ("Carasent" or the "Company") stock
exchange and press release 30 August 2024 regarding the merger plan for a
cross-border merger to the effect that shareholders will have their Carasent
shares one for one exchanged with Carasent SWE shares listed only on Nasdaq
Stockholm (the "Relisting"). Further reference is made to the Company's stock
exchange and press release 3 October 2022 regarding sale of warrants under
stock option program with terms of four (50% of the options) and five (50% of
the options) years to the chairman of the board of directors for NOK 800,000
and for the CEO for NOK 800,000.

Warrants in Carasent ASA cannot be continued in their current form after the
cross-border merger. The Company has agreed with each of the chairman and the
CEO that the warrants sold each of them by the Company in 2022 will be
cancelled, subject to, and, immediately prior to, the consummation of the
cross-border merger and Relisting. The Company will refund the purchase prices
they paid. The chairman and the CEO will use the amounts to be refunded in
open-market purchases of Carasent SWE shares. Carasent SWE will succeed to
Carasent's rights to enforce the agreement pursuant to the merger plan for the
cross-border merger.

The cross-border merger remains subject to approval by the Company's
shareholders at the extraordinary general meeting to be held on 4 October 2024
and to other conditions precedent, inter alia, obtaining relevant approvals
from Nasdaq Stockholm and relevant governmental authorities.

For further information, please contact
Svein Martin Bjørnstad, CFO Tel: +47 979 69 493

More information:
Access the news on Oslo Bors NewsWeb site

628713_Carasent ASA incentive program for chairman and CEO to be replaced by investments in Carasent SWE shares.pdf